Coravie Medical

MEKanistic Therapeutics, Inc. is a pioneering biotech company based in Minneapolis, MN, dedicated to developing innovative cancer therapies. Their breakthrough approach involves the use of a single-molecule, dual inhibitor drug that effectively blocks key pathways responsible for cancer cell growth, resulting in unparalleled tumor shrinkage in preclinical studies. With a world-class team of experts and a strong focus on KRAS-mutant cancer therapies, MEKanistic is at the forefront of advancing the field of kinase inhibitors. Backed by Invenshure, a venture studio with a proven track record in building impactful biotech companies, MEKanistic is committed to creating meaningful returns for investors while making a significant impact on the lives of patients. Their pipeline includes promising compounds such as MTX-531 and MTX-241F, which are undergoing various stages of development, aiming to bring breakthrough therapies to market and improve outcomes for cancer patients worldwide.Generated from the website

Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases. It creates an engine that completes novel and early therapeutic discovery through Phase I clinical trial completion, enabling doctors to eliminate viral-based cell therapy issues. The company was founded in 2019 and is based in Minneapolis, Minnesota.

Anatomi Corp is a technology company based in Minneapolis, MN, specializing in the development and application of advanced sensor and motor technologies. With a focus on science applications and business development, Anatomi Corp offers innovative solutions for a wide range of industries, backed by their expertise in real-time data analysis and precision engineering.Generated from the website